Upregulation of miR181a/miR212 Improves Myogenic Commitment in Murine Fusion-Negative Rhabdomyosarcoma

Authors: Enrico Pozzo, Nefele Giarratana, Gabriele Sassi, Merve Elmastas, Theo Killian, Chao-chi Wang, Vittoria Marini, Flavio Ronzoni, Jason Yustein, Anne Uyttebroeck, Maurilio Sampaolesi

Source: Frontiers in Physiology, Vol 12 (2021)

Subject Terms: rhabdomyosarcoma, skeletal muscle, murine model, pediatric cancer, microRNA, promyogenic signaling, Physiology, QP1-981

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphys.2021.701354/full; https://doaj.org/toc/1664-042X

Access URL: https://doaj.org/article/dda0a455e3b64b2d95891f3c0d344d91

Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force [version 1; peer review: 3 approved]

Authors: Kelly Bailey, Carrye Cost, Ian Davis, Julia Glade-Bender, Patrick Grohar, Peter Houghton, Michael Isakoff, Elizabeth Stewart, Nadia Laack, Jason Yustein, Damon Reed, Katherine Janeway, Richard Gorlick, Stephen Lessnick, Steven DuBois, Pooja Hingorani

Source: F1000Research, Vol 8 (2019)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: https://f1000research.com/articles/8-493/v1; https://doaj.org/toc/2046-1402

Access URL: https://doaj.org/article/443fdb2786094b91af779ecb997a6867